REAC Neurobiological Modulation as a Precision Medicine Treatment for Fibromyalgia

Area of Science:

• Neurology
• Rehabilitation Medicine
• Pain Management

Background:

• Fibromyalgia syndrome (FS) involves widespread pain and psychopathological symptoms, often linked to central pain modulation failure.
• Patients with FS exhibit dysfunctional adaptive responses to environmental and exposomal stress.
• Neuromodulation technologies offer potential therapeutic avenues for complex conditions like FS.

Purpose of the Study:

• To evaluate the effects of Radio Electric Asymmetric Conveyer (REAC) treatments on psychomotor responses and quality of life in patients with Fibromyalgia syndrome.
• To assess improvements in functional dysmetria, motor function, and quality of life following REAC-based interventions.
• To determine the efficacy of Neuro Postural Optimization (NPO) and Neuro Psycho Physical Optimization (NPPO) protocols in managing FS symptoms.

Main Methods:

• A study involving 37 patients diagnosed with Fibromyalgia syndrome.
• Utilized REAC technology, including single-session Neuro Postural Optimization (NPO) and an 18-session Neuro Psycho Physical Optimization (NPPO) cycle.
• Assessed psychomotor responses using functional dysmetria (FD), Sitting and Standing (SS), and Time Up and Go (TUG) tests; quality of life was measured by the Fibromyalgia Impact Questionnaire (FIQ).

Main Results:

• Statistically significant improvements were observed in motor response parameters and quality of life, including pain reduction.
• A significant decrease in functional dysmetria (FD) measures was noted across all participants.
• REAC treatments demonstrated a positive impact on the neurobiological balance and adaptive state of FS patients.

Conclusions:

• REAC therapeutic protocols (NPO and NPPO) effectively improved the dysfunctional adaptive state in FS patients, mitigating effects of environmental and exposomal stress.
• The findings suggest REAC treatments are a promising approach for Fibromyalgia syndrome, potentially reducing reliance on analgesic drugs.
• Improvements in psychomotor responses and quality of life indicate REAC technology's potential to enhance daily functioning for individuals with FS.